Identification and characterization of the cellular regulators of Respiratory Syncytial virus infection

Description of the granted funding

Respiratory syncytial virus (RSV) is the leading cause of viral infant death in the world. Every year, RSV is responsible for more than 30 million infections in children younger than 5 years of age, of which up to 200.000 die of the disease. In Finland, RSV has a similar incidence. No licenced vaccines are available for RSV. Most antiviral compounds usually target viral components. An alternative strategy is to target the host cell rather than the pathogen. The identification of key cellular regulators of RSV is one of the main goals of current research aimed at developing novel anti-RSV therapies. Using a combination of genetic screening approaches (siRNA and CRISPRs) and a variety of state-of-the-art super-resolution imaging techniques the research presented in this proposal aims at revealing novel cellular regulators of RSV infection and new methods to inhibit it.
Show more

Starting year

2018

End year

2023

Granted funding

Giuseppe Balistreri Orcid -palvelun logo
438 874 €

Related funding decisions

345506
Research costs of Academy Research Fellows(2021)
139 999 €
319954
Research costs of Academy Research Fellows(2018)
250 000 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Other information

Funding decision number

318434

Fields of science

Plant biology, microbiology, virology

Research fields

Mikrobiologia

Identified topics

covid, pandemic, vaccines